drugset / Trial / NCT00406094
Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to determine if patients with NARES treated with montelukast (Singulair) will have improved nasal symptom scores and reduced nasal eosinophils.
Timeline
- Start
- 2006-11
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Montelukast | Other / unclassified | 10 mg | — |